Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Stephen Frankel

Concepts (214)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pulmonary Fibrosis
8
2011
395
1.070
Why?
Vasculitis
3
2012
69
0.750
Why?
Lung Diseases
5
2012
787
0.670
Why?
Idiopathic Pulmonary Fibrosis
6
2015
697
0.570
Why?
Hospital Mortality
2
2014
1051
0.540
Why?
Critical Illness
3
2017
908
0.500
Why?
Lung Diseases, Interstitial
9
2015
677
0.460
Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
2
2012
24
0.400
Why?
Churg-Strauss Syndrome
5
2018
27
0.350
Why?
Hospitals, Veterans
1
2012
256
0.330
Why?
Arteritis
1
2010
23
0.320
Why?
Cause of Death
1
2012
456
0.310
Why?
Wounds and Injuries
2
2017
959
0.290
Why?
Fibroblasts
5
2011
1034
0.290
Why?
Eosinophilia
1
2011
224
0.290
Why?
Respiratory Tract Diseases
1
2010
178
0.280
Why?
Respiration, Artificial
2
2017
711
0.280
Why?
Granulomatosis with Polyangiitis
4
2018
48
0.260
Why?
Alveolitis, Extrinsic Allergic
1
2008
96
0.260
Why?
Colitis, Ischemic
1
2007
3
0.260
Why?
Intensive Care Units
1
2014
925
0.260
Why?
Escherichia coli O157
1
2007
14
0.260
Why?
Enterocolitis, Pseudomembranous
1
2007
29
0.260
Why?
Oxygen Inhalation Therapy
1
2009
190
0.250
Why?
Escherichia coli Infections
1
2007
125
0.240
Why?
Insulin-Like Growth Factor I
2
2004
320
0.230
Why?
Receptors, Tumor Necrosis Factor
1
2005
162
0.220
Why?
Venous Thromboembolism
1
2009
332
0.220
Why?
Connective Tissue Diseases
3
2013
85
0.210
Why?
Apoptosis
4
2011
2439
0.210
Why?
Exercise Therapy
1
2009
488
0.210
Why?
Tumor Necrosis Factor-alpha
2
2005
1224
0.200
Why?
Spike Glycoprotein, Coronavirus
2
2022
129
0.200
Why?
Precancerous Conditions
1
2004
162
0.190
Why?
Antiviral Agents
2
2021
779
0.190
Why?
Adenoma
1
2004
210
0.180
Why?
Lung
6
2014
4122
0.180
Why?
Smoking
1
2009
1486
0.180
Why?
Antibodies, Monoclonal, Humanized
3
2022
992
0.160
Why?
Humans
34
2022
146342
0.160
Why?
Hypertension, Pulmonary
2
2009
1957
0.160
Why?
Mycophenolic Acid
2
2013
117
0.150
Why?
Diagnosis, Differential
4
2011
1503
0.140
Why?
Biomarkers
1
2010
4340
0.140
Why?
fas Receptor
2
2011
91
0.140
Why?
Ganciclovir
1
2017
51
0.130
Why?
Interferon-gamma
2
2013
781
0.120
Why?
Cytomegalovirus
1
2017
172
0.120
Why?
Mutation
3
2022
4093
0.110
Why?
Cytomegalovirus Infections
1
2017
206
0.110
Why?
Aged
13
2017
26432
0.110
Why?
Middle Aged
14
2018
36619
0.110
Why?
Tomography, X-Ray Computed
5
2015
2786
0.110
Why?
Antibodies, Neutralizing
3
2022
348
0.100
Why?
Survival Rate
4
2015
2092
0.100
Why?
Antibodies, Monoclonal, Murine-Derived
1
2013
96
0.100
Why?
Male
17
2017
73396
0.100
Why?
Interleukin-6
1
2017
784
0.100
Why?
Immunosuppressive Agents
2
2018
829
0.090
Why?
Physical Therapy Modalities
1
2016
341
0.090
Why?
Aspergillosis, Allergic Bronchopulmonary
1
2011
11
0.090
Why?
Hypereosinophilic Syndrome
1
2011
9
0.090
Why?
Pulmonary Eosinophilia
1
2011
28
0.090
Why?
Pulmonary Alveoli
2
2011
385
0.090
Why?
Immunologic Factors
1
2013
244
0.080
Why?
Respiratory Insufficiency
2
2017
330
0.080
Why?
Female
16
2018
79499
0.080
Why?
Lung Neoplasms
1
2004
2675
0.080
Why?
Sepsis
1
2017
669
0.080
Why?
Bronchoscopy
1
2011
227
0.080
Why?
Rheumatic Diseases
1
2011
101
0.080
Why?
Biopsy
2
2014
1075
0.080
Why?
Antibodies, Antinuclear
1
2009
60
0.070
Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2009
19
0.070
Why?
Amino Acyl-tRNA Synthetases
1
2009
32
0.070
Why?
Idiopathic Interstitial Pneumonias
1
2009
44
0.070
Why?
Mycobacterium Infections, Nontuberculous
1
2013
339
0.070
Why?
Follow-Up Studies
4
2017
5439
0.070
Why?
Pulmonary Diffusing Capacity
3
2015
78
0.070
Why?
Up-Regulation
1
2011
841
0.070
Why?
Fatal Outcome
1
2008
302
0.070
Why?
Disease Progression
2
2015
2867
0.070
Why?
Respiratory Tract Infections
1
2011
403
0.060
Why?
Survival Analysis
1
2010
1378
0.060
Why?
Biopsy, Needle
1
2007
183
0.060
Why?
Cells, Cultured
4
2011
4118
0.060
Why?
Pericardium
1
2007
59
0.060
Why?
Cysts
1
2007
108
0.060
Why?
Acute Lung Injury
1
2010
312
0.060
Why?
Comorbidity
1
2011
1665
0.060
Why?
Anastomosis, Surgical
1
2007
164
0.060
Why?
Arthritis, Rheumatoid
1
2015
1185
0.060
Why?
Rare Diseases
1
2007
117
0.060
Why?
Colectomy
1
2007
119
0.060
Why?
Prognosis
3
2009
4351
0.060
Why?
Autoantibodies
1
2013
1500
0.060
Why?
Scleroderma, Systemic
1
2007
124
0.060
Why?
Fas-Associated Death Domain Protein
1
2005
9
0.060
Why?
Abdominal Pain
1
2007
149
0.060
Why?
Antibodies, Antineutrophil Cytoplasmic
1
2006
31
0.060
Why?
Respiratory Function Tests
3
2014
543
0.060
Why?
Acute Disease
1
2008
1038
0.060
Why?
Wound Healing
1
2008
354
0.050
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2005
79
0.050
Why?
Lung Transplantation
1
2008
326
0.050
Why?
Heart Rate
1
2009
846
0.050
Why?
Pleura
1
2004
28
0.050
Why?
Proline
1
2005
79
0.050
Why?
Protein Binding
2
2021
2244
0.050
Why?
Colonoscopy
1
2007
257
0.050
Why?
Mitogen-Activated Protein Kinase 1
1
2005
170
0.050
Why?
Hyperplasia
1
2004
164
0.050
Why?
Walking
1
2009
546
0.050
Why?
Vital Capacity
2
2015
293
0.050
Why?
Gene Expression
2
2009
1463
0.050
Why?
Echocardiography
1
2007
645
0.050
Why?
Antibiotics, Antineoplastic
1
2004
141
0.050
Why?
Interleukin-4
1
2004
207
0.050
Why?
Retrospective Studies
4
2010
17438
0.050
Why?
Bleomycin
1
2004
255
0.050
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
344
0.050
Why?
Immunohistochemistry
1
2007
1712
0.050
Why?
Polyarteritis Nodosa
1
2002
11
0.050
Why?
Takayasu Arteritis
1
2002
16
0.050
Why?
Cohort Studies
2
2015
6077
0.050
Why?
Adaptor Proteins, Signal Transducing
1
2005
429
0.050
Why?
Kaplan-Meier Estimate
2
2015
970
0.050
Why?
Incidence
1
2009
2936
0.050
Why?
Severity of Illness Index
2
2007
2921
0.040
Why?
Vaccines, Synthetic
1
2022
138
0.040
Why?
Radiography
1
2004
861
0.040
Why?
Fibrosis
1
2004
568
0.040
Why?
Age Factors
1
2009
3347
0.040
Why?
Treatment Outcome
3
2017
11821
0.040
Why?
Immunity, Humoral
1
2022
121
0.040
Why?
Antigen-Antibody Reactions
1
2021
50
0.040
Why?
Intestinal Mucosa
1
2007
666
0.040
Why?
Multivariate Analysis
2
2015
1543
0.040
Why?
Macrophages, Alveolar
1
2004
377
0.040
Why?
Longitudinal Studies
3
2014
3017
0.040
Why?
Surface Plasmon Resonance
1
2021
87
0.040
Why?
Forced Expiratory Volume
2
2015
451
0.040
Why?
Molecular Docking Simulation
1
2021
121
0.040
Why?
Receptors, Virus
1
2021
91
0.040
Why?
Ligands
1
2022
678
0.040
Why?
Aged, 80 and over
2
2010
8391
0.040
Why?
Protein Interaction Domains and Motifs
1
2021
145
0.040
Why?
Mice, Transgenic
1
2004
2134
0.040
Why?
Proportional Hazards Models
2
2015
1331
0.040
Why?
Pneumonia
1
2004
635
0.040
Why?
Cell Line
3
2011
2814
0.040
Why?
Amino Acids
1
2022
515
0.030
Why?
Kinetics
1
2021
1553
0.030
Why?
Host-Pathogen Interactions
1
2021
366
0.030
Why?
Intention to Treat Analysis
1
2017
78
0.030
Why?
Binding Sites
1
2021
1309
0.030
Why?
Virus Activation
1
2017
97
0.030
Why?
Mice
4
2011
18297
0.030
Why?
Anti-Inflammatory Agents
1
2018
474
0.030
Why?
Risk Factors
1
2009
10921
0.030
Why?
Mice, Inbred C3H
2
2005
252
0.030
Why?
RNA, Messenger
1
2022
2791
0.030
Why?
Rituximab
1
2013
208
0.020
Why?
Adult
4
2017
41087
0.020
Why?
Microscopic Polyangiitis
1
2012
13
0.020
Why?
Predictive Value of Tests
2
2009
2113
0.020
Why?
Patient Dropouts
1
2013
65
0.020
Why?
Double-Blind Method
1
2017
2070
0.020
Why?
Necrosis
1
2012
243
0.020
Why?
Fas Ligand Protein
1
2011
61
0.020
Why?
Animals
4
2011
38107
0.020
Why?
Length of Stay
1
2017
1358
0.020
Why?
Cell Line, Transformed
1
2011
137
0.020
Why?
Alanine-tRNA Ligase
1
2009
4
0.020
Why?
Threonine-tRNA Ligase
1
2009
5
0.020
Why?
Elastin
1
2009
78
0.020
Why?
Myoblasts
1
2009
84
0.020
Why?
Syndrome
1
2009
380
0.020
Why?
Oximetry
1
2009
124
0.020
Why?
Chi-Square Distribution
1
2009
517
0.020
Why?
Pulmonary Wedge Pressure
1
2007
66
0.020
Why?
Transfection
1
2009
916
0.020
Why?
Collagen
1
2009
460
0.020
Why?
Exercise Test
1
2009
637
0.010
Why?
Medical Records
1
2006
193
0.010
Why?
Consensus Sequence
1
2005
73
0.010
Why?
Asparagine
1
2005
34
0.010
Why?
NF-kappa B
1
2009
674
0.010
Why?
COS Cells
1
2005
173
0.010
Why?
Sequence Deletion
1
2005
190
0.010
Why?
Cytoplasm
1
2005
253
0.010
Why?
Serine
1
2005
142
0.010
Why?
Growth Substances
1
2004
136
0.010
Why?
Culture Media, Conditioned
1
2004
112
0.010
Why?
Mutagenesis, Site-Directed
1
2005
371
0.010
Why?
Gene Expression Profiling
1
2011
1792
0.010
Why?
Mitogen-Activated Protein Kinase 3
1
2004
134
0.010
Why?
Mice, Knockout
1
2011
3125
0.010
Why?
Logistic Models
1
2009
2126
0.010
Why?
Th2 Cells
1
2004
179
0.010
Why?
Protein Structure, Tertiary
1
2005
834
0.010
Why?
Epithelial Cells
1
2009
1119
0.010
Why?
Cell Communication
1
2004
327
0.010
Why?
Proto-Oncogene Proteins c-akt
1
2004
441
0.010
Why?
Cell Proliferation
1
2009
2502
0.010
Why?
Cell Membrane
1
2005
701
0.010
Why?
Case-Control Studies
1
2009
3647
0.010
Why?
Cell Survival
1
2004
1105
0.010
Why?
Proto-Oncogene Proteins
1
2004
616
0.010
Why?
Inflammation
1
2012
2919
0.010
Why?
Phosphorylation
1
2005
1724
0.010
Why?
Prospective Studies
1
2011
8123
0.010
Why?
Young Adult
1
2009
14330
0.010
Why?
Adolescent
1
2009
22557
0.000
Why?
Frankel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)